Junyi He

2.0k total citations
64 papers, 1.0k citations indexed

About

Junyi He is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Junyi He has authored 64 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Junyi He's work include Landslides and related hazards (8 papers), Cancer-related molecular mechanisms research (6 papers) and Sarcoma Diagnosis and Treatment (5 papers). Junyi He is often cited by papers focused on Landslides and related hazards (8 papers), Cancer-related molecular mechanisms research (6 papers) and Sarcoma Diagnosis and Treatment (5 papers). Junyi He collaborates with scholars based in China, United States and Denmark. Junyi He's co-authors include Yangzhe Wu, Yan Xu, Zhinan Yin, Lin Li, Jiawei Li, Weiqi Lu, Dieter Kabelitz, Yan Chen, Léonce Kouakanou and Christian Peters and has published in prestigious journals such as Biomaterials, Hepatology and The FASEB Journal.

In The Last Decade

Junyi He

51 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junyi He China 19 369 254 240 197 100 64 1.0k
Yu‐Shiuan Wang Taiwan 21 569 1.5× 191 0.8× 211 0.9× 144 0.7× 171 1.7× 54 1.3k
Shaoli Zhang China 17 328 0.9× 193 0.8× 276 1.1× 142 0.7× 171 1.7× 44 1.1k
Wu Zhang United States 20 582 1.6× 171 0.7× 521 2.2× 237 1.2× 273 2.7× 84 1.3k
Xiaoyun Mao China 22 893 2.4× 152 0.6× 500 2.1× 571 2.9× 198 2.0× 83 1.7k
Haibo Xiao China 21 685 1.9× 209 0.8× 364 1.5× 425 2.2× 174 1.7× 58 1.3k
Ya Hu China 23 552 1.5× 141 0.6× 487 2.0× 350 1.8× 181 1.8× 86 1.6k
Changsheng Ye China 18 321 0.9× 58 0.2× 182 0.8× 247 1.3× 79 0.8× 58 813

Countries citing papers authored by Junyi He

Since Specialization
Citations

This map shows the geographic impact of Junyi He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyi He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyi He more than expected).

Fields of papers citing papers by Junyi He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyi He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyi He. The network helps show where Junyi He may publish in the future.

Co-authorship network of co-authors of Junyi He

This figure shows the co-authorship network connecting the top 25 collaborators of Junyi He. A scholar is included among the top collaborators of Junyi He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyi He. Junyi He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Junyi, et al.. (2025). JFG-HMR: 3D joint feature-guided human mesh recovery with global–local feature fusion. Computers & Graphics. 132. 104339–104339.
2.
He, Junyi, et al.. (2025). LINC00870 promotes imatinib resistance in gastrointestinal stromal tumor via inhibiting PIGR glycosylation modifications. Heliyon. 11(3). e41934–e41934. 1 indexed citations
3.
Zhang, Zheng, Huaxiang Xu, Junyi He, et al.. (2025). Inhibition of KLF5 promotes ferroptosis via the ZEB1/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells. Cell Death and Disease. 16(1). 28–28. 6 indexed citations
4.
Meng, Fangfang, Qing Lyu, Wenjie Zhu, et al.. (2025). Intraoperative pathological diagnosis for breast cancer with a polarity fluorescent probe targeting lipid droplets. Sensors and Actuators B Chemical. 443. 138305–138305.
5.
6.
He, Junyi, Qun Hu, & Lipo Wang. (2025). Multi-regime turbulent spray combustion modeling by similarity mapping. Combustion and Flame. 279. 114271–114271.
7.
He, Junyi, Xiaoqing Wang, Jingze Zhang, et al.. (2025). The Impact of Radiation Dose to Immune Cells in Stage IV Non-Small Cell Lung Cancer in the Era of Immunotherapy. Clinical Lung Cancer. 26(3). 221–227.e1.
8.
9.
Yu, Xin‐Yao, Junyi He, Fei Tang, et al.. (2023). Highly sensitive determination of l-glutamic acid in pig serum with an enzyme-free molecularly imprinted polymer on a carbon-nanotube modified electrode. Analytical Methods. 15(42). 5589–5597. 7 indexed citations
10.
11.
Chen, Qiangda, Hanlin Yin, Junyi He, et al.. (2023). Tumor Microenvironment Responsive CD8+ T Cells and Myeloid‐Derived Suppressor Cells to Trigger CD73 Inhibitor AB680‐Based Synergistic Therapy for Pancreatic Cancer. Advanced Science. 10(33). e2302498–e2302498. 17 indexed citations
12.
Hou, Feng, Duan‐Bo Shi, Xiangyu Guo, et al.. (2023). HRCT1, negatively regulated by miR-124-3p, promotes tumor metastasis and the growth of gastric cancer by activating the ERBB2-MAPK pathway. Gastric Cancer. 26(2). 250–263. 7 indexed citations
13.
Meng, Fangfang, Tiantian Liu, Junyi He, et al.. (2023). Real-time and in situ visualizing the details of mitochondrial fragmentation with a leakage-free fluorescent probe in living cells. Sensors and Actuators B Chemical. 393. 134328–134328.
14.
Sun, Yujing, Yuan Tian, Junyi He, et al.. (2022). Linc01133 contributes to gastric cancer growth by enhancing YES1-dependent YAP1 nuclear translocation via sponging miR-145-5p. Cell Death and Disease. 13(1). 51–51. 23 indexed citations
15.
Huang, Yue, Jieying Yang, Qiuzhong Pan, et al.. (2022). CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma. Cell Death and Disease. 13(3). 251–251. 35 indexed citations
16.
Zheng, Jiajia, Hanxing Tong, Jing Xu, et al.. (2021). RP11-616M22.7 recapitulates imatinib resistance in gastrointestinal stromal tumor. Molecular Therapy — Nucleic Acids. 25. 264–276. 13 indexed citations
17.
18.
Sun, Yujing, Junyi He, Duan‐Bo Shi, et al.. (2020). Elevated ZBTB7A expression in the tumor invasive front correlates with more tumor budding formation in gastric adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 147(1). 105–115. 9 indexed citations
19.
Hu, Yi, Ting Liu, Jingxia Li, et al.. (2019). Selenium nanoparticles as new strategy to potentiate γδ T cell anti-tumor cytotoxicity through upregulation of tubulin-α acetylation. Biomaterials. 222. 119397–119397. 91 indexed citations
20.
He, Junyi, Sheng Shen, Weiqi Lu, et al.. (2016). HDAC1 promoted migration and invasion binding with TCF12 by promoting EMT progress in gallbladder cancer. Oncotarget. 7(22). 32754–32764. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu‐Shiuan Wang Breakdown of academic impact, for papers by Shaoli Zhang Breakdown of academic impact, for papers by Wu Zhang Breakdown of academic impact, for papers by Xiaoyun Mao Breakdown of academic impact, for papers by Haibo Xiao Breakdown of academic impact, for papers by Ya Hu Breakdown of academic impact, for papers by Changsheng Ye
Rankless by CCL
2026